IRadimed
IRMD
#6108
Rank
A$1.56 B
Marketcap
A$122.09
Share price
-1.28%
Change (1 day)
-8.50%
Change (1 year)
Categories

Earnings for IRadimed (IRMD)

Earnings in 2026 (TTM): A$45.3 Million

According to IRadimed's latest financial reports the company's current earnings are A$89.33 Million. In 2025 the company made an earning of A$42.6 Million, an increase over its 2024 earnings that were of A$36.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IRadimed from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$45.3 M6.32%
2025 A$42.6 M16.82%
2024 A$36.47 M11.67%
2023 A$32.65 M34.35%
2022 A$24.3 M64.5%
2021 A$14.77 M-1694.53%
2020 -A$0.93 Million-106.82%
2019 A$13.58 M45.92%
2018 A$9.31 M343.81%
2017 A$2.09 M-87.25%
2016 A$16.45 M-5.86%
2015 A$17.47 M285.59%
2014 A$4.53 M8.39%
2013 A$4.18 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Edwards Lifesciences
EW
A$2.23 B 4,670.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NuVasive
NUVA
A$91.53 M 95.80%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.91 B 4,000.19%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
A$33.01 M-29.38%๐Ÿ‡บ๐Ÿ‡ธ USA